You are here

• Home
• Therapy Areas
• Respiratory/Inflammation

• A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Inhaled Doses of AZD2115 in Healthy Male Subjects

Disease

pharmacodynamics, pharmacokinetics

Generic Name

AZD2115

Sponsor

AstraZeneca

Drug Status

In Development

Phase

I

Start Date

Jan 18, 1971

Study Name

D3060C00002

Study Id

D3060C00002

ClinicalTrials.gov ID

NCT01445782

Recruiting Status

Closed

Protocol Status

Not Available

Report Status

Not Available

Page tools

• Print
• Bookmark this page